AR and polycystic ovary syndrome: This suggests that the regulation of gene expression by AR in PCOS hESCs in response to elevated androgen levels is primarily via binding at putative enhancer sites, and that there could also be a role in intron retention (19) due to the other major proportion of AR binding being in introns.